December 05, 2025 16:00 ET | Source: Humanoid Global Holdings Corp. – NOT FOR DISSEMINATION IN THE UNITED STATES OR…
Appointment of Marc Le Bozec as Interim CEO Nantes, October 3, 2025, 8:00 a.m. CET – OSE Immunotherapeutics (ISIN: FR0012127173;…